Showing results (161-170 of 1,193) with videos related to

Sort By:
Pageof 120
JACC. Heart Failure|December 14, 2020
Heart Failure Hospitalization and Guideline-Directed Prescribing Patterns Among Heart Failure With Reduced Ejection Fraction PatientsPratyaksh K Srivastava, Adam D DeVore, Anne S Hellkamp, et al.
JACC. Heart Failure|November 15, 2020
Worsening Kidney Function Is the Major Mechanism of Heart Failure in Hypertension: The ALLHAT StudyMaedeh Khayyat-Kholghi, Suzanne Oparil, Barry R Davis, et al.
JACC. Heart Failure|July 11, 2021
Prognostic Value of Urinary and Plasma C-Type Natriuretic Peptide in Acute Decompensated Heart FailureXiao Ma, Yang Chen, Shawn H Reginauld, et al.
JACC. Heart Failure|July 11, 2021
NT-proBNP for Risk Prediction in Heart Failure: Identification of Optimal Cutoffs Across Body Mass Index CategoriesGiuseppe Vergaro, Francesco Gentile, Laura M G Meems, et al.
JACC. Heart Failure|October 30, 2020
Complete Hemodynamic Profiling With Pulmonary Artery Catheters in Cardiogenic Shock Is Associated With Lower In-Hospital MortalityA Reshad Garan, Manreet Kanwar, Katherine L Thayer, et al.
JACC. Heart Failure|October 11, 2020
Estimating the Lifetime Benefits of Treatments for Heart FailureJoão Pedro Ferreira, Kieran F Docherty, Susan Stienen, et al.
JACC. Heart Failure|July 30, 2021
Mineralocorticoid Receptor Antagonist Improves Cardiac Structure in Type 2 Diabetes: Data From the MIRAD TrialNiels H Brandt-Jacobsen, Per Lav Madsen, Marie Louise Johansen, et al.
JACC. Heart Failure|July 30, 2021
Impact of Diabetes on Outcomes After Transcatheter Mitral Valve Repair in Heart Failure: COAPT TrialBahira Shahim, Ori Ben-Yehuda, Shmuel Chen, et al.
JACC. Heart Failure|July 30, 2021
Patient Phenotypes and SGLT-2 Inhibition in Type 2 Diabetes: Insights From the EMPA-REG OUTCOME TrialAbhinav Sharma, Anne Pernille Ofstad, Tariq Ahmad, et al.
Pageof 120